Group 1 - The core point of the article highlights the continued high enthusiasm for public fund research, with 125 public fund institutions participating in A-share company research during the week of May 12-18, 2025, covering 210 stocks across 76 secondary industries, resulting in a total of 972 research instances [1] - Among the stocks, 69 were researched at least 5 times, with 46 stocks receiving 5-9 instances, 16 stocks receiving 10-19 instances, and 7 stocks being researched at least 20 times [1] Group 2 - The top ten stocks by research frequency were all researched at least 16 times, with Anji Technology leading at 57 instances, attracting over 30% of public fund participation, making it the "research king" [2] - Following Anji Technology, Aobi Zhongguang received 30 public fund institution visits, indicating strong market interest in its 3D vision technology [3] - Huadong Medicine ranked third with 29 research instances, recognized for its growth potential driven by innovative drugs and medical aesthetics [3] Group 3 - The top ten researched stocks were primarily concentrated in technology innovation, healthcare, and consumer sectors, reflecting public funds' strategy to focus on high-quality targets aligned with national industrial policy and long-term growth potential [3] - The semiconductor industry topped the research frequency with 76 instances, indicating strong expectations for domestic semiconductor replacement processes, with companies like Canray Technology and Demingli receiving significant attention [3] - The general equipment industry followed with 60 research instances, showing institutions' intent for comprehensive layout in high-end equipment manufacturing [3]
上周公募调研近千次,安集科技成最受关注个股